NCT05134337View on ClinicalTrials.gov

Study of the Effects of Itraconazole and Rifampin on LOXO-305 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

February 12, 2020

Primary Completion Date

October 30, 2020

Study Completion Date

October 30, 2020

Conditions
Healthy Volunteers
Interventions
DRUG

LOXO-305

Oral LOXO-305

DRUG

Itraconazole

Oral itraconazole

DRUG

Rifampin

Oral rifampin

Trial Locations (1)

32117

Covance Clinical Research Unit, Daytona Beach

Sponsors
All Listed Sponsors
lead

Loxo Oncology, Inc.

INDUSTRY

NCT05134337 - Study of the Effects of Itraconazole and Rifampin on LOXO-305 in Healthy Participants | Biotech Hunter | Biotech Hunter